review of glp 1 GLP-1 Medications: Everything You Need to Know 2024 in Review: The Rise

The shared biological properties of exendin-4 and human GLP-1 probably stem from their primary and secondary structures, but exendin-4 is naturally resistant to degradation by the DPP-4 enzyme, attributed to the presence of glycine at position 2, resulting in an intravenous half-life of approximately 30 minutes (85)

After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025

If its been more than 5 days, skip that dose and take your next dose on your regular day

One review showed that people lost about 4 lbs of body weight when taking berberine regularly (500 mg daily)